NEOCELLA Trademark

Trademark Overview


On Friday, December 2, 2022, a trademark application was filed for NEOCELLA with the United States Patent and Trademark Office. The USPTO has given the NEOCELLA trademark a serial number of 79364057. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by NEOCELLA INC.. The NEOCELLA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Veterinary preparations for oncology, cancers; vaccines; non-prescription medicines for oncology, cancers; contrast media for in vivo imaging; radioactive pharmaceutical preparations for in vivo diagnostics and therapeutic use; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents in the form of biologics, capsule, tablet; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic agents for medical purposes; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; contrast media for use in medical imaging; biological preparations for medical or veterinary purposes, namely, for the treatment of cancer; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic ...

Cell separation research services; development of cell therapy products; drug discovery services; research to develop new products in the field of oncology and precision medicine, cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Pharmaceutical drug development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical drug development services; consultancy pertaining to pharmacology; medicine research; stem cell research services; DNA analysis for scientific research purposes; consultation and providing information in the field of biomedicine research and development; research relating to crude drugs; biochemical analysis; clinical research in the field of medicine; scientific research services for medical purposes
neocella

General Information


Serial Number79364057
Word MarkNEOCELLA
Filing DateFriday, December 2, 2022
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7483879
Registration DateTuesday, August 27, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesVeterinary preparations for oncology, cancers; vaccines; non-prescription medicines for oncology, cancers; contrast media for in vivo imaging; radioactive pharmaceutical preparations for in vivo diagnostics and therapeutic use; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents in the form of biologics, capsule, tablet; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic agents for medical purposes; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; contrast media for use in medical imaging; biological preparations for medical or veterinary purposes, namely, for the treatment of cancer; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; antibodies for medical purposes; Pharmaceutical preparations for oncology and precision medicine, cancer; radioisotope markers for therapeutic or diagnostic use
Goods and ServicesCell separation research services; development of cell therapy products; drug discovery services; research to develop new products in the field of oncology and precision medicine, cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Pharmaceutical drug development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical drug development services; consultancy pertaining to pharmacology; medicine research; stem cell research services; DNA analysis for scientific research purposes; consultation and providing information in the field of biomedicine research and development; research relating to crude drugs; biochemical analysis; clinical research in the field of medicine; scientific research services for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNEOCELLA INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS

Party NameNEOCELLA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUS

Party NameNEOCELLA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUS

Trademark Events


Event DateEvent Description
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Thursday, March 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 7, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, September 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 20, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 2, 2023REFUSAL PROCESSED BY MPU
Monday, October 2, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 25, 2023REFUSAL PROCESSED BY IB
Tuesday, March 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 8, 2024ASSIGNED TO EXAMINER
Tuesday, May 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 31, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 31, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, August 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED